Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer

Traditionally the stratification of many cancers involves combining tumour and clinicopathological features (e.g., patient age; tumour size, grade, receptor status and location) to inform treatment options and predict recurrence risk and survival. However, current biomarkers often require invasive e...

Descripción completa

Detalles Bibliográficos
Autores principales: McAnena, Peter, Brown, James A. L., Kerin, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295776/
https://www.ncbi.nlm.nih.gov/pubmed/28075351
http://dx.doi.org/10.3390/cancers9010005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295776/
https://www.ncbi.nlm.nih.gov/pubmed/28075351
http://dx.doi.org/10.3390/cancers9010005

Ejemplares similares